Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects

NCT05256017 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1208

Enrollment

OTHER

Sponsor class

Conditions

Trypanosomiasis, African
Trypanosoma Brucei Gambiense; Infection
Sleeping Sickness

Interventions

DRUG: Acoziborole
DRUG: Placebo

Sponsor

Drugs for Neglected Diseases